Compare Core Scientific Inc (CORZ) vs Crocs, Inc. (CROX) Price & Performance

CORZ trades at $15.25, down 4.36% today amid a bearish technical trend. The stock shows weak fundamentals with a net loss of $288.62 million in 2025 and negative profit margins, though revenue is projected to grow to $440 million in 2026. Analyst sentiment remains strongly bullish with an 86% buy rating and a $32.75 consensus price target, but recent earnings misses and high cash burn pose significant risks.

The outlook is mixed: strong analyst support and insider buying suggest confidence in the AI data center strategy, but persistent losses, negative cash flow, and competitive pressures require careful monitoring. The stock's current price near support levels offers potential upside if execution improves, yet volatility and operational challenges present substantial downside risk.

Crocs (CROX) trades at $115.20, down 4.18% amid bearish technical signals, though recent earnings beats and a 51% analyst buy rating suggest underlying strength. The stock shows attractive valuation with a P/E of 10.37 and strong profitability metrics including 57.47% gross margin and 42.3% ROE. Management is focusing on product innovation and HEYDUDE brand reset to drive growth.

Despite near-term price pressure, CROX offers value with consensus price target of $136.78 (19% upside). Risks include recent net income decline to -$81M and competitive pressures in footwear. The company's cash flow generation and brand positioning support long-term recovery potential.